Patent details
300019
Product Name:
Insuline glargine,desgewenst in de vorm van een fysiologisch geschikt zout.
The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
Ok
Cancel
You have not selected any documents
Ok
Basic Information
Publication number:
300019
Type:
Certificate
SPC Type:
Medical
Basic Patent Number:
EP0368187
Status:
Expired Art. 14 (a) of the EC Regulations
Application number:
300019
Procedural language:
Dutch
First Applicant Residence Country:
Paediatric Extension
SPC Extension Filing Date:
17/10/2012
SPC Extension Agent/Owner Name:
ir. C.M. Jansen c.s.
, Sanofi-Aventis Deutschland GmbH
SPC Extension Status:
Extension Granted
SPC Extension Grant Date:
14/11/2012
SPC Extension Request Refusal Date:
SPC Extension Revocation Date:
Marketing Authorization
1
Marketing Authorization Number:
EU/1/00/134/001
Marketing Authorization Type:
EEA
Marketing Authorization Date:
09/06/2000
Marketing Authorization Country:
European Union (EU)
2
Marketing Authorization Number:
EU/1/00/134/002
Marketing Authorization Type:
EEA
Marketing Authorization Date:
09/06/2000
Marketing Authorization Country:
European Union (EU)
3
Marketing Authorization Number:
EU/1/00/134/003
Marketing Authorization Type:
EEA
Marketing Authorization Date:
09/06/2000
Marketing Authorization Country:
European Union (EU)
4
Marketing Authorization Number:
EU/1/00/134/004
Marketing Authorization Type:
EEA
Marketing Authorization Date:
09/06/2000
Marketing Authorization Country:
European Union (EU)
5
Marketing Authorization Number:
EU/1/00/134/005
Marketing Authorization Type:
EEA
Marketing Authorization Date:
09/06/2000
Marketing Authorization Country:
European Union (EU)
6
Marketing Authorization Number:
EU/1/00/134/006
Marketing Authorization Type:
EEA
Marketing Authorization Date:
09/06/2000
Marketing Authorization Country:
European Union (EU)
7
Marketing Authorization Number:
EU/1/00/134/007
Marketing Authorization Type:
EEA
Marketing Authorization Date:
09/06/2000
Marketing Authorization Country:
European Union (EU)
8
Marketing Authorization Number:
EU/1/00/134/001
Marketing Authorization Type:
National/EU
Marketing Authorization Date:
09/06/2000
Marketing Authorization Country:
European Union (EU)
9
Marketing Authorization Number:
EU/1/00/134/002
Marketing Authorization Type:
National/EU
Marketing Authorization Date:
09/06/2000
Marketing Authorization Country:
European Union (EU)
10
Marketing Authorization Number:
EU/1/00/134/003
Marketing Authorization Type:
National/EU
Marketing Authorization Date:
09/06/2000
Marketing Authorization Country:
European Union (EU)
11
Marketing Authorization Number:
EU/1/00/134/004
Marketing Authorization Type:
National/EU
Marketing Authorization Date:
09/06/2000
Marketing Authorization Country:
European Union (EU)
12
Marketing Authorization Number:
EU/1/00/134/005
Marketing Authorization Type:
National/EU
Marketing Authorization Date:
09/06/2000
Marketing Authorization Country:
European Union (EU)
13
Marketing Authorization Number:
EU/1/00/134/006
Marketing Authorization Type:
National/EU
Marketing Authorization Date:
09/06/2000
Marketing Authorization Country:
European Union (EU)
14
Marketing Authorization Number:
EU/1/00/134/007
Marketing Authorization Type:
National/EU
Marketing Authorization Date:
09/06/2000
Marketing Authorization Country:
European Union (EU)
Dates
Filing date:
20/09/2000
First Marketing Authorization date:
09/06/2000
Grant date:
28/11/2000
Activation date:
06/11/2009
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Registration date:
20/09/2000
SPC/SPC Extension Expiration Date:
05/05/2015
Lapsed By Expiration Date:
06/05/2015
Withdrawal date:
Revocation Date:
Invalidity Date:
Withdrawal Market Authorization Date:
Refusal Date:
Applicant/holder
From:
11/11/2005
Name:
Sanofi-Aventis Deutschland GmbH
Address:
Brüningstrasse 50, 65929, Frankfurt am Main, Germany (DE)
Historical Applicant/holder
From:
01/10/2001
To:
11/11/2005
Name:
Aventis Pharma Deutschland GmbH
Address:
Industriepark Höchst Gebäude K 801, D-65926, Frankfurt am Main, Germany (DE)
From:
20/09/2000
To:
01/10/2001
Name:
HOECHST AKTIENGESELLSCHAFT
Address:
Postfach 80 03 20, D-65926, Frankfurt am Main, Germany (DE)
Agent
Name:
ir. C.M. Jansen c.s.
From:
20/09/2000
Address:
V.O.
Postbus 87930, 2508 DH, Den Haag, Netherlands (NL)
To:
Publication
Bulletin
1
Bulletin Heading:
VRV
Journal edition number:
2015/20
Publication date:
13/05/2015
Description:
Lapse or annulment
2
Bulletin Heading:
MED
Journal edition number:
2012/47
Publication date:
21/11/2012
Description:
Other communications
3
Bulletin Heading:
MED
Journal edition number:
2012/43
Publication date:
24/10/2012
Description:
Other communications
4
Bulletin Heading:
MED
Journal edition number:
2006/02
Publication date:
01/02/2006
Description:
Other communications
5
Bulletin Heading:
CO
Journal edition number:
2002/01
Publication date:
02/01/2002
Description:
Changes in the Netherlands Patent Register
6
Bulletin Heading:
SPC
Journal edition number:
2001/02
Publication date:
01/02/2001
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)
7
Bulletin Heading:
SPC
Journal edition number:
2000/12
Publication date:
01/12/2000
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)
Deed
Change of owner(s)
Change Kind/ Decision Type:
Change of owner(s) name
Deed Number:
47031-A047031-1
Date Registered:
11/11/2005
License Effective Date:
License Expiration Date:
Scope of License:
Deed Filer:
ir. C.M. Jansen c.s.
Journal Edition Number:
Text:
Deed Status:
Country Code:
Updated License Number:
Terminated License Number:
Changed Pledgee
Name:
Address:
Removed Usufructuary
Name:
Address:
Added Usufructuary
Name:
Address:
Changed Usufructuary
Name:
Address:
Change of owner(s)
Change Kind/ Decision Type:
Assignment
Deed Number:
39699-A039699-1
Date Registered:
01/10/2001
License Effective Date:
License Expiration Date:
Scope of License:
Deed Filer:
ir. C.M. Jansen c.s.
Journal Edition Number:
Text:
Deed Status:
Country Code:
Updated License Number:
Terminated License Number:
Changed Pledgee
Name:
Address:
Removed Usufructuary
Name:
Address:
Added Usufructuary
Name:
Address:
Changed Usufructuary
Name:
Address:
Annual Fee
Annual Fee(s) Due Date:
Annual Fee Number:
Last Annual Payment Date:
27/11/2014
Last Annual Fee Paid Number:
26
Last Annual Fee Paid Amount:
1300 Euro
Payer:
Arnold & Siedsma BV
Filing date
Document type
Document Description
Number of pages
File Type
16/10/2012
Outgoing Correspondence
Outgoing Letter
1
PDF
/9/1/0/0/0/0400300019/docs/300019_7_outgoingcorrespondence20121016.pdf
15/10/2012
Incoming Correspondence Paper
Other
4
PDF
/9/1/0/0/0/0400300019/docs/300019_0_incomingcorrespondencepaper20121015.pdf
15/10/2012
Incoming Correspondence Paper
Other
2
PDF
/9/1/0/0/0/0400300019/docs/300019_4_incomingcorrespondencepaper20121015.pdf
28/11/2000
Outgoing Correspondence
Outgoing Letter
1
PDF
/9/1/0/0/0/0400300019/docs/300019_3_outgoingcorrespondence20001128.pdf
28/11/2000
Outgoing Correspondence
Outgoing Letter
1
PDF
/9/1/0/0/0/0400300019/docs/300019_5_outgoingcorrespondence20001128.pdf
28/11/2000
Outgoing Correspondence
Outgoing Letter
1
PDF
/9/1/0/0/0/0400300019/docs/300019_6_outgoingcorrespondence20001128.pdf
28/11/2000
Outgoing Correspondence
Outgoing Letter
1
PDF
/9/1/0/0/0/0400300019/docs/300019_10_outgoingcorrespondence20001128.pdf
03/11/2000
Outgoing Correspondence
Outgoing Letter
2
PDF
/9/1/0/0/0/0400300019/docs/300019_1_outgoingcorrespondence20001103.pdf
01/11/2000
General
1
PDF
/9/1/0/0/0/0400300019/docs/300019_2_spc-documents20001101.pdf
01/11/2000
General
19
PDF
/9/1/0/0/0/0400300019/docs/300019_12_spc-documents20001101.pdf
20/09/2000
Application Form
First filed application form
2
PDF
/9/1/0/0/0/0400300019/docs/300019_8_applicationform20000920.pdf
20/09/2000
General
2
PDF
/9/1/0/0/0/0400300019/docs/300019_9_spc-documents20000920.pdf
20/09/2000
General
8
PDF
/9/1/0/0/0/0400300019/docs/300019_11_spc-documents20000920.pdf